Omnicell announced strong financial results for the second quarter of 2021, with record revenues of $273 million and GAAP net income per diluted share of $0.43. The company's performance reflects robust demand for its solutions and services.
Achieved record revenue in the second quarter.
Reported record non-GAAP net income per diluted share.
Advanced Services portfolio continues to gain momentum in the market.
Announced intent to acquire FDS Amplicare to strengthen Advanced Services portfolio.
For the third quarter of 2021, Omnicell expects total revenues to be between $281 million and $286 million and non-GAAP earnings to be between $0.89 and $0.94 per share.
Analyze how earnings announcements historically affect stock price performance